Since HSPs are highly expressed in the inflamed tissues of patients with numerous autoimmune diseases [6–14], HSP peptides would be ideal antigens for tolDC loading, not only for the treatment of RA, but also for tolDC-based treatments of other autoimmune diseases. This evidence concerns the gene HSP90B2P and rheumatoid arthritis.